• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Crude Oil Moves Higher; Bristol Myers Squibb Shares Fall After Q1 Results

    4/25/24 2:32:33 PM ET
    $ATNI
    $BMY
    $HTZ
    $JAKK
    Telecommunications Equipment
    Telecommunications
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ATNI alert in real time by email

    U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling by around 100 points on Thursday.

    The Dow traded down 1.20% to 37,998.27 while the NASDAQ fell 0.85% to 15,578.58. The S&P 500 also fell, dropping, 0.70% to 5,035.88.

    Check This Out: How To Earn $500 A Month From T-Mobile US Stock Ahead Of Q1 Earnings Report

    Leading and Lagging Sectors

    Materials shares rose by 0.7% on Thursday.

    In trading on Thursday, communication services shares dipped by 4%.

    Top Headline

    Shares of Bristol Myers Squibb & Co (NYSE:BMY) fell more than 8% during Thursday's session after the company swung to a loss in the first quarter.

    The company posted first-quarter revenues of $11.9 billion, beating the consensus of $11.5 billion, an increase of 5% year-over-year. The company reported an adjusted EPS loss of $(4.40), compared to an income of $2.05 a year ago, beating the consensus loss of $(4.44).

    Bristol Myers Squibb revised 2024 adjusted EPS guidance from $7.10-$7.40 to $0.40-$0.70 versus consensus of $0.66, reflecting the impact of recent transactions.

    Equities Trading UP     

    • Impinj, Inc. (NASDAQ:PI) shares shot up 26% to $152.87 after reporting better-than-expected first-quarter financial results.
    • Shares of Ultralife Corporation (NASDAQ:ULBI) got a boost, surging 21% to $10.56 after the company reported better-than-expected quarterly financial results.
    • Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) shares were also up, gaining 44% to $2.34 after HC Wainwright & Co initiated coverage on the stock with a Buy rating and announced an $8 price target.

    Equities Trading DOWN

    • ATN International, Inc. (NASDAQ:ATNI) shares dropped 34% to $19.00 as the company posted weak quarterly sales and slashed FY24 revenue forecast.
    • Shares of Hertz Global Holdings, Inc. (NASDAQ:HTZ) were down 20% to $4.6450 after the company mixed first-quarter financial results.
    • JAKKS Pacific, Inc. (NASDAQ:JAKK) was down, falling 18% to $19.33 following a wider-than-expected quarterly loss.

    Also Check This Out: Meta Platforms To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Thursday

    Commodities

    In commodity news, oil traded up 0.6% to $83.28 while gold traded up 0.2% at $2,343.60.

    Silver traded up 0.1% to $27.38 on Thursday, while copper rose 2% to $4.5445.

    Euro zone

    European shares were mostly lower today. The eurozone's STOXX 600 fell 0.64%, London's FTSE 100 rose 0.48% while Spain's IBEX 35 Index fell 0.40% The German DAX fell 0.95% French CAC 40 fell 0.93% while Italy's FTSE MIB Index fell 0.97%.

    Producer prices in Spain fell 8.2% year-over-year in March compared to a revised 8.5% decline in February. The GfK Consumer Climate Indicator for Germany climbed to -24.2 heading into May versus a revised reading of -27.3 in the prior period. UK's car production fell 27.1% to 59,467 units for March.

    Asia Pacific Markets

    Asian markets closed mostly higher on Thursday, with Japan's Nikkei 225 falling 2.16%, Hong Kong's Hang Seng Index gaining 0.48%, China's Shanghai Composite climbing 0.27% and India's S&P BSE Sensex gaining 0.66%.

    Hong Kong's trade deficit increased to $45.0 billion in March from $40.6 billion in the year-ago month. The index of leading economic indicators in Japan came in unchanged at 111.8 in February, while index of coincident economic indicators was revised higher to 111.6 in February versus a flash reading of 110.9.

    Economics

    • U.S. initial jobless claims declined by 5,000 to 207,000 in the week ending April 20, compared to market estimates of 214,000.
    • The U.S. economy grew an annualized 1.6% in the first quarter, marking a notable slowdown from the 3.4% rate in the final quarter of 2023. However, analysts were expecting a 2.5% growth.
    • U.S. wholesale inventories fell by 0.4% month-over-month in March compared to a revised 0.4% gain in February.
    • Pending home sales in the U.S. climbed by 3.4% month-over-month in March.
    • The core price index for personal consumption expenditures increased by an annualized 3.7% in the first quarter versus a 2% gain in the prior three-month period.
    • The EIA said US natural-gas supplies rose 92 billion cubic feet during the week ended April 19.

    Now Read This: Jim Cramer: You’re ‘Dice Rolling’ With This Biopharma Stock, But Vista Energy Is ‘A Good Situation’

    Get the next $ATNI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATNI
    $BMY
    $HTZ
    $JAKK

    CompanyDatePrice TargetRatingAnalyst
    Bristol-Myers Squibb Company
    $BMY
    2/25/2026$60.00Sector Perform
    RBC Capital Mkts
    Bristol-Myers Squibb Company
    $BMY
    2/20/2026$75.00Overweight
    Barclays
    Impinj Inc.
    $PI
    2/6/2026$112.00Outperform → In-line
    Evercore ISI
    Bristol-Myers Squibb Company
    $BMY
    1/7/2026$65.00Neutral → Buy
    UBS
    Bristol-Myers Squibb Company
    $BMY
    12/15/2025$61.00Neutral → Buy
    BofA Securities
    Bristol-Myers Squibb Company
    $BMY
    12/12/2025$62.00Neutral → Buy
    Guggenheim
    Bristol-Myers Squibb Company
    $BMY
    11/13/2025$45.00Sector Perform
    Scotiabank
    Impinj Inc.
    $PI
    11/7/2025$200.00Neutral
    UBS
    More analyst ratings

    $ATNI
    $BMY
    $HTZ
    $JAKK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on Bristol-Myers with a new price target

    RBC Capital Mkts initiated coverage of Bristol-Myers with a rating of Sector Perform and set a new price target of $60.00

    2/25/26 7:49:08 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Barclays initiated coverage on Bristol-Myers with a new price target

    Barclays initiated coverage of Bristol-Myers with a rating of Overweight and set a new price target of $75.00

    2/20/26 8:24:06 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Impinj downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded Impinj from Outperform to In-line and set a new price target of $112.00

    2/6/26 8:09:28 AM ET
    $PI
    Industrial Machinery/Components
    Technology

    $ATNI
    $BMY
    $HTZ
    $JAKK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by West W Gilbert

    4 - HERTZ GLOBAL HOLDINGS, INC (0001657853) (Issuer)

    4/2/26 5:23:03 PM ET
    $HTZ
    Rental/Leasing Companies
    Consumer Discretionary

    SEC Form 4 filed by Neal James R

    4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)

    4/2/26 5:12:17 PM ET
    $PCSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Shanahan Karin

    4 - BRISTOL MYERS SQUIBB CO (0000014272) (Issuer)

    4/2/26 4:30:43 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ATNI
    $BMY
    $HTZ
    $JAKK
    SEC Filings

    View All

    SEC Form 15-12G filed by Bristol-Myers Squibb Company

    15-12G - BRISTOL MYERS SQUIBB CO (0000014272) (Filer)

    3/27/26 4:05:11 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Impinj Inc.

    SCHEDULE 13G/A - IMPINJ INC (0001114995) (Subject)

    3/27/26 9:53:18 AM ET
    $PI
    Industrial Machinery/Components
    Technology

    JAKKS Pacific Inc. filed SEC Form 8-K: Leadership Update

    8-K - JAKKS PACIFIC INC (0001009829) (Filer)

    3/27/26 9:04:28 AM ET
    $JAKK
    Recreational Games/Products/Toys
    Consumer Discretionary

    $ATNI
    $BMY
    $HTZ
    $JAKK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Impinj to Announce First-Quarter 2026 Financial Results

    Impinj, Inc. (NASDAQ:PI), a leading RAIN RFID provider and Internet of Things pioneer, today announced that it will release financial results for its first quarter ended March 31, 2026, after U.S. markets close on Wednesday, April 29, 2026. Impinj will host a conference call and webcast to discuss its first-quarter 2026 results and second-quarter 2026 outlook at 5:00 p.m. ET / 2:00 p.m. PT. Interested parties may listen to the call by dialing +1-412-317-1863. A live webcast and replay will be available on the company's website at investor.impinj.com. Following the call, a telephonic replay will be available for five business days and may be accessed by dialing +1-412-317-0088 and entering

    4/2/26 4:15:00 PM ET
    $PI
    Industrial Machinery/Components
    Technology

    Bristol Myers Squibb Evolves and Expands Standing in the Gaap to Advance More Equitable Care in Multiple Myeloma as Program Marks Ten Years

    New survey, guided by patient advocacy input, seeks to elevate lived experience and community voice to better understand challenges in multiple myeloma care Bristol Myers Squibb (NYSE:BMY), a global leader in oncology, today announced the evolution of Standing in the Gaap, a long-running program designed to help address persistent gaps in care for people living with multiple myeloma (MM) in medically underserved communities. Building on a decade of sustained commitment, BMS is reinforcing its focus on equitable access to multiple myeloma education, resources, and community-driven solutions by expanding the program to reach more patients and care partners. As a central element of the Sta

    3/31/26 6:59:00 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bristol Myers Squibb Presents Positive Results from Phase 3 SCOUT-HCM Trial Demonstrating Efficacy and Safety of Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

    Trial met its primary endpoint, demonstrating clinically meaningful and statistically significant reduction in Valsalva left ventricular outflow tract (LVOT) gradient at Week 28 Results demonstrate the potential for Camzyos to be the first targeted pharmacological therapy for the treatment of oHCM in adolescents Safety profile of Camzyos in adolescents was similar to established profile in adults, with no new safety signals and no patients experiencing left ventricular ejection fraction (LVEF) of <50% Bristol Myers Squibb (NYSE:BMY) today announced positive data from the Phase 3 SCOUT-HCM trial of Camzyos (mavacamten), the first study of a cardiac myosin inhibitor (CMI) in adolescents

    3/29/26 11:45:00 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ATNI
    $BMY
    $HTZ
    $JAKK
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 26, 2024 - FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia

    For Immediate Release: September 26, 2024 Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.   “Schizophrenia is a leading

    9/26/24 6:42:20 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 14, 2024 - FDA Roundup: June 14, 2024

    For Immediate Release: June 14, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a proposed exemption for certain cottage cheese products from the requirements of the Food Traceability Rule. The proposal would exempt Grade “A” cottage cheese that appears on the Interstate Milk Shippers List from the requirements of the r

    6/14/24 3:54:45 PM ET
    $MMSI
    $BMY
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    March 8, 2024 - FDA Roundup: March 8, 2024

    For Immediate Release: March 08, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced proposed new regulations to provide animal drug sponsors with predictable requirements for the labeling of prescription and over-the-counter new animal drugs, as well as new animal drugs for use in animal feeds. The proposed content and

    3/8/24 3:26:46 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ATNI
    $BMY
    $HTZ
    $JAKK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Whitmore Bradford T bought $1,196,909 worth of shares (187,512 units at $6.38) (SEC Form 4)

    4 - ULTRALIFE CORP (0000875657) (Issuer)

    3/16/26 4:25:31 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    President and CEO Manna Michael Edward bought $12,024 worth of Ultralife Common Stock; $.10 par value (2,000 units at $6.01), increasing direct ownership by 8% to 26,874 units (SEC Form 4)

    4 - ULTRALIFE CORP (0000875657) (Issuer)

    3/16/26 4:13:07 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    Director Whitmore Bradford T bought $300,902 worth of shares (53,000 units at $5.68) (SEC Form 4)

    4 - ULTRALIFE CORP (0000875657) (Issuer)

    12/16/25 4:32:26 PM ET
    $ULBI
    Industrial Machinery/Components
    Miscellaneous

    $ATNI
    $BMY
    $HTZ
    $JAKK
    Leadership Updates

    Live Leadership Updates

    View All

    Alaska Communications Strengthens Carrier & Wholesale Services with New Leadership

    Alaska Communications is enhancing its carrier and wholesale services organization to deliver greater value for partners and customers with the appointment of Jesse Kleinbach as the new vice president of the organization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260119649040/en/Pictured: Jesse Kleinbach. With more than 25 years in telecom, Kleinbach brings expertise in creating solutions that help partners succeed. He has led initiatives that simplify connectivity, expand market opportunities, and ensure customers receive reliable, innovative services. In his new role, Kleinbach will focus on expanding service options, i

    1/19/26 11:00:00 AM ET
    $ATNI
    Telecommunications Equipment
    Telecommunications

    Alaska Communications Welcomes John Sims to Board of Directors

    Alaska Communications is pleased to announce the appointment of John Sims, President of ENSTAR Natural Gas Company, to its Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251124343374/en/Pictured: John Sims. Born and raised in Eagle River, Sims brings deep Alaska roots and a lifelong commitment to serving the unique needs of Alaskans. His extensive leadership experience, including nearly two decades at ENSTAR, reflects a proven ability to guide organizations through growth and challenges while keeping community at the forefront. Under his leadership, ENSTAR has strengthened its role as a trusted energy provider

    11/24/25 2:20:00 PM ET
    $ATNI
    Telecommunications Equipment
    Telecommunications

    Hertz Appoints Piero Bussani as Chief Legal Officer

    Hertz Global Holdings, Inc. (NASDAQ:HTZ) ("Hertz" or the "Company"), a leading global car rental company, today announced that Piero Bussani is joining the company as Executive Vice President and Chief Legal Officer, effective October 27, to lead global legal affairs, government affairs and sustainability and social impact. "Piero brings strategic thinking and operational experience as we continue to transform Hertz," said Gil West, CEO of Hertz. "He brings a track record from complex, consumer-focused companies, from high-growth startups to large-scale enterprises, and understands how to lead legal functions that enable the business to move with speed and discipline. I'm confident he'll

    10/22/25 4:30:00 PM ET
    $CUBE
    $HTZ
    Real Estate Investment Trusts
    Real Estate
    Rental/Leasing Companies
    Consumer Discretionary

    $ATNI
    $BMY
    $HTZ
    $JAKK
    Financials

    Live finance-specific insights

    View All

    Impinj to Announce First-Quarter 2026 Financial Results

    Impinj, Inc. (NASDAQ:PI), a leading RAIN RFID provider and Internet of Things pioneer, today announced that it will release financial results for its first quarter ended March 31, 2026, after U.S. markets close on Wednesday, April 29, 2026. Impinj will host a conference call and webcast to discuss its first-quarter 2026 results and second-quarter 2026 outlook at 5:00 p.m. ET / 2:00 p.m. PT. Interested parties may listen to the call by dialing +1-412-317-1863. A live webcast and replay will be available on the company's website at investor.impinj.com. Following the call, a telephonic replay will be available for five business days and may be accessed by dialing +1-412-317-0088 and entering

    4/2/26 4:15:00 PM ET
    $PI
    Industrial Machinery/Components
    Technology

    Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026

    Bristol Myers Squibb (NYSE:BMY) will announce results for the first quarter of 2026 on Thursday, April 30, 2026. Company executives will review financial results with the investment community during a conference call beginning at 8:00 a.m. ET. Investors and the general public are invited to listen to a live audio webcast of the call at http://investor.bms.com. Materials related to the call will be available on the company's Investor Relations website prior to the start of the conference call. A replay of the webcast will be available here approximately three hours after the conference call concludes. About Bristol Myers Squibb: Transforming Patients' Lives Through Science At Bristol

    3/19/26 6:59:00 AM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ATN Board Declares Quarterly Dividend

    BEVERLY, Mass., March 18, 2026 (GLOBE NEWSWIRE) -- ATN International, Inc. (NASDAQ:ATNI) announced that its Board of Directors has declared a quarterly dividend of $0.275 per share, payable on April 10, 2026, on all common shares outstanding to stockholders of record as of March 31, 2026. About ATN ATN International, Inc. (NASDAQ:ATNI), headquartered in Beverly, Massachusetts, is a provider of digital infrastructure and communications services in the United States and internationally, including the Caribbean region, with a focus on rural and remote markets with a growing demand for infrastructure investments. The Company's operating subsidiaries today primarily provide: (i) advanced wire

    3/18/26 4:15:00 PM ET
    $ATNI
    Telecommunications Equipment
    Telecommunications

    $ATNI
    $BMY
    $HTZ
    $JAKK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Impinj Inc.

    SC 13D/A - IMPINJ INC (0001114995) (Subject)

    11/12/24 4:46:57 PM ET
    $PI
    Industrial Machinery/Components
    Technology

    Amendment: SEC Form SC 13G/A filed by Impinj Inc.

    SC 13G/A - IMPINJ INC (0001114995) (Subject)

    11/12/24 3:56:16 PM ET
    $PI
    Industrial Machinery/Components
    Technology

    Amendment: SEC Form SC 13G/A filed by ATN International Inc.

    SC 13G/A - ATN International, Inc. (0000879585) (Subject)

    11/12/24 1:29:28 PM ET
    $ATNI
    Telecommunications Equipment
    Telecommunications